{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:12:37Z","timestamp":1792069957166,"version":"4.4.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,6]],"date-time":"2014-04-06T00:00:00Z","timestamp":1396742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00726-014-1736-9","type":"journal-article","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T05:55:27Z","timestamp":1396677327000},"page":"1727-1750","source":"Crossref","is-referenced-by-count":196,"title":["Involvement of substance P and the NK-1 receptor in human pathology"],"prefix":"10.1007","volume":"46","author":[{"given":"Miguel","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cove\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,6]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00520-011-1341-3","volume":"20","author":"MH Abidi","year":"2012","unstructured":"Abidi MH, Tageja N, Ayash L, Abrams J, Ratanatharathorn V, Al-Kadhimi Z, Lum L, Cronin S, Ventimiglia M, Uberti J (2012) Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial. Support Care Cancer 20:2363\u20132369","journal-title":"Support Care Cancer"},{"key":"1736_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0173(94)90002-7","volume":"19","author":"JA Angulo","year":"1994","unstructured":"Angulo JA, McEwen BS (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev 19:1\u201328","journal-title":"Brain Res Brain Res Rev"},{"key":"1736_CR3","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1097\/00002030-199818000-00006","volume":"12","author":"P Annunziata","year":"1998","unstructured":"Annunziata P, Cioni C, Toneatto S, Paccagnini E (1998) HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS 12:2377\u20132385","journal-title":"AIDS"},{"key":"1736_CR4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1095\/biolreprod53.4.814","volume":"53","author":"PC Arck","year":"1995","unstructured":"Arck PC, Merali FS, Stanisz AM, Stead RH, Chaouat G, Manuel J, Clark DA (1995) Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol Reprod 53:814\u2013819","journal-title":"Biol Reprod"},{"key":"1736_CR5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cne.901960312","volume":"196","author":"DM Armstrong","year":"1981","unstructured":"Armstrong DM, Pickel VM, Joh TH, Reis DJ, Miller RJ (1981) Immunocytochemical localization of catecholamine synthesizing enzymes and neuropeptides in the area postrema and medial nucleus tractus solitarius of rat brain. J Comp Neurol 196:505\u2013517","journal-title":"J Comp Neurol"},{"key":"1736_CR6","first-page":"577","volume":"14","author":"C Azzari","year":"1992","unstructured":"Azzari C, Rossi ME, Resti M, Caldini AL, Lega L, Galli L, Fico E, Vierucci A (1992) Changed levels of substance P and somatostatin in HIV-positive children. Pediatr Med Chir 14:577\u2013581","journal-title":"Pediatr Med Chir"},{"key":"1736_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neulet.2010.03.051","volume":"475","author":"MN Baek","year":"2010","unstructured":"Baek MN, Jung KH, Halder D, Choi MR, Lee BH, Lee BC, Jung MH, Choi IG, Chung MK, Oh DY, Chai YG (2010) Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice. Neurosci Lett 475:124\u2013128","journal-title":"Neurosci Lett"},{"key":"1736_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.102.043539","volume":"305","author":"R Bang","year":"2003","unstructured":"Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL, Tiegs G (2003) Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J Pharmacol Exp Ther 305:31\u201339","journal-title":"J Pharmacol Exp Ther"},{"key":"1736_CR9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/jpet.103.059329","volume":"308","author":"R Bang","year":"2004","unstructured":"Bang R, Biburger M, Neuhuber WL, Tiegs G (2004) Neurokinin-1 receptor antagonists protect mice from CD95- and tumor necrosis factor-alpha-mediated apoptotic liver damage. J Pharmacol Exp Ther 308:1174\u20131180","journal-title":"J Pharmacol Exp Ther"},{"key":"1736_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.phrs.2012.10.022","volume":"68","author":"C Bardelli","year":"2013","unstructured":"Bardelli C, Amoruso A, Manzetti E, Fresu LG, Valsesia R, Zeppegno P, Brunelleschi S (2013) Recurrent major depressive disorder: imbalance of neurokinin (NK)-1 and NK-2 receptor expression in monocytes. Pharmacol Res 68:24\u201330","journal-title":"Pharmacol Res"},{"key":"1736_CR11","doi-asserted-by":"crossref","unstructured":"Berger M, Neth O, Ilmer M, Garnier A, Salinas-Mart\u00edn MV, de Agust\u00edn Asencio JC, von Schweinitz D, Kappler R, Mu\u00f1oz M (2014) Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol (in press)","DOI":"10.1016\/j.jhep.2013.12.024"},{"key":"1736_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","volume":"8","author":"H Bolay","year":"2002","unstructured":"Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136\u2013142","journal-title":"Nat Med"},{"key":"1736_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.drudis.2012.05.004","volume":"17","author":"D Borsook","year":"2012","unstructured":"Borsook D, Upadhyay J, Klimas M, Schwarz AJ, Coimbra A, Baumgartner R, George E, Potter WZ, Large T, Bleakman D, Evelhoch J, Iyengar S, Becerra L, Hargreaves RJ (2012) Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain. Drug Discov Today 17:964\u2013973","journal-title":"Drug Discov Today"},{"key":"1736_CR14","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(93)90673-6","volume":"249","author":"C Bountra","year":"1993","unstructured":"Bountra C, Bunce K, Dale K, Gardner C, Jordan C, Twissell D, Ward P (1993) Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets. Eur J Pharmacol 249:R3\u2013R4","journal-title":"Eur J Pharmacol"},{"key":"1736_CR15","first-page":"2323","volume":"29","author":"S Brener","year":"2009","unstructured":"Brener S, Gonz\u00e1lez-Moles MA, Tostes D, Esteban F, Gil-Montoya JA, Ruiz-Avila I, Bravo M, Mu\u00f1oz M (2009) A role for the substance P\/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res 29:2323\u20132329","journal-title":"Anticancer Res"},{"key":"1736_CR16","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1460-9568.2005.04002.x","volume":"21","author":"R Carletti","year":"2005","unstructured":"Carletti R, Corsi M, Melotto S, Caberlotto L (2005) Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci 21:1712\u20131718","journal-title":"Eur J Neurosci"},{"key":"1736_CR17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.cdd.4401035","volume":"9","author":"S Castro-Obreg\u00f3n","year":"2002","unstructured":"Castro-Obreg\u00f3n S, del R\u00edo G, Chen SF, Swanson RA, Frankowski H, Rao RV, Stoka V, Vesce S, Nicholls DG, Bredesen DE (2002) A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 9:807\u2013817","journal-title":"Cell Death Differ"},{"key":"1736_CR18","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.4049\/jimmunol.180.12.8241","volume":"180","author":"VS Chauhan","year":"2008","unstructured":"Chauhan VS, Sterka DG Jr, Gray DL, Bost KL, Marriott I (2008) Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol 180:8241\u20138249","journal-title":"J Immunol"},{"key":"1736_CR19","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.4049\/jimmunol.1100721","volume":"186","author":"VS Chauhan","year":"2011","unstructured":"Chauhan VS, Kluttz JM, Bost KL, Marriott I (2011) Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis. J Immunol 186:7255\u20137263","journal-title":"J Immunol"},{"key":"1736_CR20","first-page":"392","volume":"18","author":"HE Connor","year":"1998","unstructured":"Connor HE (1998) Clinical evaluation of a novel, potent, CNS penetrating NK-1 receptor antagonist in the acute treatment of migraine. Cephalalgia 18:392","journal-title":"Cephalalgia"},{"key":"1736_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cne.901780108","volume":"178","author":"AC Cuello","year":"1978","unstructured":"Cuello AC, Kanazawa I (1978) The distribution of substance P immunoreactive fibres in the rat central nervous system. J Comp Neurol 178:129\u2013156","journal-title":"J Comp Neurol"},{"key":"1736_CR22","first-page":"235","volume":"7","author":"NC Lanerolle de","year":"1992","unstructured":"de Lanerolle NC, Brines M, Williamson A, Kim JH, Spencer DD (1992) Neurotransmitters and their receptors in human temporal lobe epilepsy. Epilepsy Res 7:235\u2013250","journal-title":"Epilepsy Res"},{"key":"1736_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-2982.2003.00496.x","volume":"23","author":"HC Diener","year":"2003","unstructured":"Diener HC (2003) RPR100893 Study Group. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23:183\u2013185","journal-title":"Cephalalgia"},{"key":"1736_CR24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0009-9236(98)90140-0","volume":"64","author":"RA Dionne","year":"1998","unstructured":"Dionne RA, Max MB, Gordon SM, Parada S, Sang C, Gracely RH, Sethna NF, MacLean DB (1998) The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clin Pharmacol Ther 64:562\u2013568","journal-title":"Clin Pharmacol Ther"},{"key":"1736_CR25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jlb.64.6.828","volume":"64","author":"S Dunzendorfer","year":"1998","unstructured":"Dunzendorfer S, Meierhofer C, Wiedermann CJ (1998) Signaling in neuropeptide-induced migration of human eosinophils. J Leukocyte Biol 64:828\u2013834","journal-title":"J Leukocyte Biol"},{"key":"1736_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","volume":"31","author":"K Ebner","year":"2006","unstructured":"Ebner K, Singewald N (2006) The role of substance P in stress and anxiety responses. Amino Acids 31:251\u2013272","journal-title":"Amino Acids"},{"key":"1736_CR27","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1073\/pnas.0400794101","volume":"101","author":"K Ebner","year":"2004","unstructured":"Ebner K, Rupniak NM, Saria A, Singewald N (2004) Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101:4280\u20134285","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2174\/138161209788168074","volume":"15","author":"K Ebner","year":"2009","unstructured":"Ebner K, Sartori SB, Singewald N (2009) Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des 15:1647\u20131674","journal-title":"Curr Pharm Des"},{"key":"1736_CR29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2559.2008.03193.x","volume":"54","author":"F Esteban","year":"2009","unstructured":"Esteban F, Gonz\u00e1lez-Moles MA, Castro D, Mart\u00edn-Ja\u00e9n MM, Redondo M, Ruiz-Avila I, Rosso M, Mu\u00f1oz M (2009) Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology 54:258\u2013260","journal-title":"Histopathology"},{"key":"1736_CR30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.200802081","volume":"181","author":"OT Fackler","year":"2008","unstructured":"Fackler OT, Grosse R (2008) Cell motility through plasma membrane blebbing. J Cell Biol 181:879\u2013884","journal-title":"J Cell Biol"},{"key":"1736_CR31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-0115(03)00193-9","volume":"116","author":"C Feistritzer","year":"2003","unstructured":"Feistritzer C, Clausen J, Sturn DH, Djanani A, Gunsilius E, Wiedermann CJ, Kahler CM (2003) Natural killer cell functions mediated by the neuropeptide substance P. Regul Pept 116:119\u2013126","journal-title":"Regul Pept"},{"key":"1736_CR500","doi-asserted-by":"crossref","unstructured":"Fong TM, Yu H, Strader CD (1992) Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP-67,580. J Biol Chem 267:25668\u201325671","DOI":"10.1016\/S0021-9258(18)35658-8"},{"key":"1736_CR32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.LAB.0000067499.57309.F6","volume":"83","author":"H Friess","year":"2003","unstructured":"Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A, Reubi JC, Buchler MW (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest 83:731\u2013742","journal-title":"Lab Invest"},{"key":"1736_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.03.029","volume":"58","author":"T Furmark","year":"2005","unstructured":"Furmark T, Appel L, Michelgard A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergstr\u00f6m M, Pich EM, Nilsson LG, Bani M, L\u00e5ngstr\u00f6m B, Fredrikson M (2005) Cerebral blood flow changes after treatment of social phobia with the eurokinin-1 antagonist GR-205,171, citalopram, or placebo. Biol Psychiatry 58:132\u2013142","journal-title":"Biol Psychiatry"},{"key":"1736_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","volume":"128","author":"E Fusayasu","year":"2007","unstructured":"Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K (2007) Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128:209\u2013214","journal-title":"Pain"},{"key":"1736_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1468-29821995.1505384.x","volume":"15","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Flofidi A, Francceschini M, Codini M, Trequattrini A, Palumbo R (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:384\u2013390","journal-title":"Cephalalgia"},{"key":"1736_CR36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-8993(86)91347-8","volume":"382","author":"DS Garant","year":"1986","unstructured":"Garant DS, Iadarola MJ, Gale K (1986) Substance P antagonists in substantia nigra are anticonvulsant. Brain Res 382:372\u2013378","journal-title":"Brain Res"},{"key":"1736_CR37","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.1153813","volume":"319","author":"DT George","year":"2008","unstructured":"George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M (2008) Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319:1536\u20131539","journal-title":"Science"},{"key":"1736_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of human during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"1736_CR39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","volume":"17","author":"DJ Goldstein","year":"1997","unstructured":"Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785\u2013790","journal-title":"Cephalalgia"},{"key":"1736_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002826-200101000-00004","volume":"24","author":"DJ Goldstein","year":"2001","unstructured":"Goldstein DJ, Wang O, Gitter BD, Iyengar S (2001) Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy. Clin Neuropharmacol 24:16\u201322","journal-title":"Clin Neuropharmacol"},{"key":"1736_CR41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.oraloncology.2008.02.010","volume":"44","author":"MA Gonz\u00e1lez-Moles","year":"2008","unstructured":"Gonz\u00e1lez-Moles MA, Mosqueda-Taylor A, Esteban F, Gil-Montoya JA, D\u00edaz-Franco MA, Delgado M, Mu\u00f1oz M (2008) Cell proliferation associated with actions of the substance P\/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 44:1127\u20131133","journal-title":"Oral Oncol"},{"key":"1736_CR42","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood-2003-11-3979","volume":"104","author":"GJ Graham","year":"2004","unstructured":"Graham GJ, Stevens JM, Page NM, Grant AD, Brain SD, Lowry PJ, Gibbins JM (2004) Tachykinins regulate the function of platelets. Blood 104:1058\u20131065","journal-title":"Blood"},{"key":"1736_CR43","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.juro.2006.08.018","volume":"176","author":"SA Green","year":"2006","unstructured":"Green SA, Alon A, Ianus J, McNaughton KS, Tozzi CA, Reiss TF (2006) Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence. J Urol 176:2535\u20132540","journal-title":"J Urol"},{"key":"1736_CR44","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1158\/0008-5472.CAN-04-3197","volume":"65","author":"S Guha","year":"2005","unstructured":"Guha S, Eibl G, Kisfalvi K, Fan RS, Burdick M, Reber H, Hines OJ, Strieter R, Rozengurt E (2005) Broad-spectrum G protein\u2013coupled receptor antagonist, [D-Arg1, DTrp5,7,9, Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 65:2738\u20132745","journal-title":"Cancer Res"},{"key":"1736_CR45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","volume":"33","author":"S Harrison","year":"2001","unstructured":"Harrison S, Geppetti P (2001) Substance P. Int J Biochem Cell Biol 33:555\u2013576","journal-title":"Int J Biochem Cell Biol"},{"key":"1736_CR46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1172\/JCI114571","volume":"85","author":"G Harrowe","year":"1990","unstructured":"Harrowe G, Mitsuhashi M, Payan DG (1990) Measles virus-substance P receptor interactions. Possible novel mechanism of viral fusion. J Clin Invest 85:1324\u20131327","journal-title":"J Clin Invest"},{"key":"1736_CR47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1189\/jlb.0407217","volume":"82","author":"A Hegde","year":"2007","unstructured":"Hegde A, Zhang H, Moochhala SM, Bhatia M (2007) Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J Leukoc Biol 82:678\u2013685","journal-title":"J Leukoc Biol"},{"key":"1736_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2119\/molmed.2009.00166","volume":"16","author":"A Hegde","year":"2010","unstructured":"Hegde A, Tamizhselvi R, Manikandan J, Melendez AJ, Moochhala SM, Bhatia M (2010a) Substance P in polymicrobial sepsis: molecular fingerprint of lung injury in preprotachykinin-A \u2212\/\u2212 mice. Mol Med 16:188\u2013198","journal-title":"Mol Med"},{"key":"1736_CR49","doi-asserted-by":"crossref","first-page":"601098","DOI":"10.4061\/2010\/601098","volume":"2010","author":"A Hegde","year":"2010","unstructured":"Hegde A, Koh YH, Moochhala SM, Bhatia M (2010b) Neurokinin-1 receptor antagonist treatment in polymicrobial sepsis: molecular insights. Int J Inflam 2010:601098","journal-title":"Int J Inflam"},{"key":"1736_CR50","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1200\/JCO.2009.21.8511","volume":"27","author":"J Herrstedt","year":"2009","unstructured":"Herrstedt J, Apornwirat W, Shaharyar A, Aziz Z, Roila F, Van Belle S, Russo MW, Levin J, Ranganathan S, Guckert M, Gunberg SM (2009) Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy. J Clin Oncol 27:5363\u20135369","journal-title":"J Clin Oncol"},{"key":"1736_CR51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1200\/JCO.1999.17.1.338","volume":"17","author":"PJ Hesketh","year":"1999","unstructured":"Hesketh PJ, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL (1999) Randomized Phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. J Clin Oncol 17:338\u2013343","journal-title":"J Clin Oncol"},{"key":"1736_CR52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","volume":"21","author":"R Hill","year":"2000","unstructured":"Hill R (2000) NK1 (substance P) receptor antagonists: why are they not analgesic in humans? Trends Pharmacol Sci 21:244\u2013246","journal-title":"Trends Pharmacol Sci"},{"key":"1736_CR53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/aid.1996.12.195","volume":"12","author":"WZ Ho","year":"1996","unstructured":"Ho WZ, Cnaan A, Li YH, Zhao H, Lee HR, Song L, Douglas SD (1996) Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses 12:195\u2013198","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1736_CR54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1073\/pnas.75.2.1013","volume":"74","author":"T H\u00f6kfelt","year":"1978","unstructured":"H\u00f6kfelt T, Pernow B, Nilsson G, Wetterberg L, Goldstein M, Jeffcoate SL (1978) Dense plexus of substance P-immunoreactive nerve terminals in eminentia medialis of the primate hypothalamus. Proc Natl Acad Sci USA 74:1013\u20131015","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR55","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0028-3908(00)00010-1","volume":"39","author":"T H\u00f6kfelt","year":"2000","unstructured":"H\u00f6kfelt T, Broberger C, David Xu Z-Q, Sergeyev V, Ubink R, Diez M (2000) Neuropeptides: an overview. Neuropharmacology 39:1337\u20131356","journal-title":"Neuropharmacology"},{"key":"1736_CR56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.0954-6820.2000.00773.x","volume":"249","author":"T H\u00f6kfelt","year":"2001","unstructured":"H\u00f6kfelt T, Pernow B, Wahren J (2001) Substance P: a pioneer amongst neuropeptides. J Intern Med 249:27\u201340","journal-title":"J Intern Med"},{"key":"1736_CR57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0306-4522(88)90064-4","volume":"24","author":"P Holzer","year":"1988","unstructured":"Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739\u2013768","journal-title":"Neuroscience"},{"key":"1736_CR58","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2008-06-163121","volume":"113","author":"BM Janelsins","year":"2009","unstructured":"Janelsins BM, Mathers AR, Tkacheva OA, Erdos G, Shufesky WJ, Morelli AE, Larregina AT (2009) Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood 113:3017\u20133026","journal-title":"Blood"},{"key":"1736_CR59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.02.043","volume":"360","author":"JH Jang","year":"2004","unstructured":"Jang JH, Nam TS, Paik KS, Leem JW (2004) Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Lett 360:129\u2013132","journal-title":"Neurosci Lett"},{"key":"1736_CR60","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1528-1167.2009.02482.x","volume":"51","author":"M Kalinichev","year":"2010","unstructured":"Kalinichev M, Bradford A, Bison S, Lucas A, Sartori I, Garbati N, Andreetta F, Bate S, Austin NE, Jones DN, Read KD, Alvaro G, Large CH (2010) Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the rat. Epilepsia 51:1543\u20131551","journal-title":"Epilepsia"},{"key":"1736_CR61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","volume":"59","author":"M Keller","year":"2006","unstructured":"Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, Hargreaves R, Hietala J, Lines C, Beebe K, Reines S (2006) Lack of efficacy of the substance P (neurokinin-1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59:216\u2013223","journal-title":"Biol Psychiatry"},{"key":"1736_CR62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1165\/ajrcmb.24.2.4264","volume":"24","author":"KA King","year":"2001","unstructured":"King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G (2001) Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24:101\u2013107","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1736_CR63","first-page":"391","volume":"7","author":"FJ Ko","year":"1991","unstructured":"Ko FJ, Chiang CH, Liu WJ, Chiang W (1991) Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders. Gaoxiong Yi Xue Ke Xue Za Zhi 7:391\u2013397","journal-title":"Gaoxiong Yi Xue Ke Xue Za Zhi"},{"key":"1736_CR64","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","volume":"281","author":"MS Kramer","year":"1998","unstructured":"Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Halle JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlsson EJ, Hargreaves RJ, Rupniak NM (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640\u20131645","journal-title":"Science"},{"key":"1736_CR65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.npp.1300260","volume":"29","author":"MS Kramer","year":"2004","unstructured":"Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y (2004) Demonstration of the efficacy and safety of a novel substance P (NK-1) receptor antagonist in major depression. Neuropsychopharmacology 29:385\u2013392","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-5728(98)00170-2","volume":"91","author":"JP Lai","year":"1998","unstructured":"Lai JP, Douglas SD, Rappaport E, Wu JM, Ho WZ (1998) Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 91:121\u2013128","journal-title":"J Neuroimmunol"},{"key":"1736_CR67","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#","volume":"29","author":"BN Lambrecht","year":"1999","unstructured":"Lambrecht BN, Germonpre PR, Everaert EG, Carro-Muino I, De Veerman M, de Felipe C, Hunt SP, Thielemans K, Joos GF, Pauwels RA (1999) Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 29:3815\u20133825","journal-title":"Eur J Immunol"},{"key":"1736_CR68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112:231\u2013238","journal-title":"Int J Cancer"},{"key":"1736_CR69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1476-5381.1992.tb09013.x","volume":"105","author":"F Lembeck","year":"1992","unstructured":"Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A (1992) The non-peptide tachykinin antagonist, CP-96.345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 105:527\u2013530","journal-title":"Br J Pharmacol"},{"key":"1736_CR70","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.159.10.4952","volume":"159","author":"K Lieb","year":"1997","unstructured":"Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K (1997) The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159:4952\u20134958","journal-title":"J Immunol"},{"key":"1736_CR71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1471-4159.2003.01802.x","volume":"86","author":"KL Lieb","year":"2003","unstructured":"Lieb KL, Treffurth Y, Hamke M, Akundi RS, von Kleinsorgen M, Fiebich BL (2003) Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor. J Neurochem 86:69\u201376","journal-title":"J Neurochem"},{"key":"1736_CR72","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1073\/pnas.96.21.12096","volume":"96","author":"H Liu","year":"1999","unstructured":"Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R, Wasterlain CG (1999) Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc Natl Acad Sci USA 96:12096\u201312101","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR73","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.2457950","volume":"241","author":"M Lotz","year":"1988","unstructured":"Lotz M, Vaughan JH, Carson DA (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241:1218\u20131221","journal-title":"Science"},{"key":"1736_CR74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-328X(93)90172-L","volume":"18","author":"H Maeno","year":"1993","unstructured":"Maeno H, Kiyama H, Tohyama M (1993) Distribution of the substance P (NK1) receptor in the central nervous system. Mol Brain Res 18:43\u201358","journal-title":"Mol Brain Res"},{"key":"1736_CR75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0306-4522(86)90041-2","volume":"17","author":"JK Mai","year":"1986","unstructured":"Mai JK, Stephens PH, Hopf A, Cuello AC (1986) Substance P in the human brain. Neuroscience 17:709\u2013739","journal-title":"Neuroscience"},{"key":"1736_CR76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virol.2007.02.033","volume":"362","author":"NR Makhortova","year":"2007","unstructured":"Makhortova NR, Askovich P, Patterson CE, Gechman LA, Gerard NP, Rall GF (2007) Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 362:235\u2013244","journal-title":"Virology"},{"key":"1736_CR77","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1097\/QAD.0b013e3283405c33","volume":"24","author":"MM Manak","year":"2010","unstructured":"Manak MM, Moshkoff DA, Nguyen LT, Meshki J, Tebas P, Tuluc F, Douglas SD (2010) Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. AIDS 24:2789\u20132796","journal-title":"AIDS"},{"key":"1736_CR78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(99)00182-4","volume":"102","author":"I Marriott","year":"2000","unstructured":"Marriott I, Mason MJ, Elhofy A, Bost KL (2000) Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol 102:163\u2013171","journal-title":"J Neuroimmunol"},{"key":"1736_CR79","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1074\/jbc.M808825200","volume":"284","author":"J Meshki","year":"2009","unstructured":"Meshki J, Douglas SD, Lai JP, Schwartz L, Kilpatrick LE, Tuluc F (2009) Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho\/Rho-associated coiled-coil kinase-dependent mechanism. J Biol Chem 284:9280\u20139289","journal-title":"J Biol Chem"},{"key":"1736_CR80","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/092986710790416308","volume":"17","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Cove\u00f1as R (2010) A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem 17:504\u2013516","journal-title":"Curr Med Chem"},{"key":"1736_CR81","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2174\/092986711795496746","volume":"18","author":"M Mu\u00f1oz","year":"2011","unstructured":"Mu\u00f1oz M, Cove\u00f1as R (2011) NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Curr Med Chem 18:1820\u20131831","journal-title":"Curr Med Chem"},{"key":"1736_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.07.024","volume":"48","author":"M Mu\u00f1oz","year":"2013","unstructured":"Mu\u00f1oz M, Cove\u00f1as R (2013a) Involvement of substance P and the NK-1 receptor in cancer. Peptides 48:1\u20139","journal-title":"Peptides"},{"key":"1736_CR83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/14740338.2013.804059","volume":"12","author":"M Mu\u00f1oz","year":"2013","unstructured":"Mu\u00f1oz M, Cove\u00f1as R (2013b) Safety of neurokinin-1 receptor antagonists. Expert Opin Drug Saf 12:673\u2013685","journal-title":"Expert Opin Drug Saf"},{"key":"1736_CR84","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.05-1591","volume":"48","author":"M Mu\u00f1oz","year":"2007","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R, Montero I, Gonz\u00e1lez-Moles MA, Robles MJ (2007) Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Invest Ophthalmol Vis Sci 48:2775\u20132781","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1736_CR85","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/labinvest.2010.92","volume":"90","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M, Robles-Fr\u00edas MJ, Salinas-Mart\u00edn MV, Cove\u00f1as R (2010) The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines. Lab Invest 90:1259\u20131269","journal-title":"Lab Invest"},{"key":"1736_CR86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.peptides.2012.09.024","volume":"38","author":"M Mu\u00f1oz","year":"2012","unstructured":"Mu\u00f1oz M, Gonz\u00e1lez-Ortega A, Rosso M, Robles-Fr\u00edas MJ, Carranza A, Salinas-Mart\u00edn MV, Cove\u00f1as R (2012) The substance P\/Neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides 38:318\u2013325","journal-title":"Peptides"},{"key":"1736_CR87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/ijo.2013.2164","volume":"44","author":"M Mu\u00f1oz","year":"2014","unstructured":"Mu\u00f1oz M, Berger M, Rosso M, Gonz\u00e1lez-Ortega A, Carranza A, Cove\u00f1as R (2014) Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts. Int J Oncol 44:137\u2013146","journal-title":"Int J Oncol"},{"key":"1736_CR88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/35012069","volume":"405","author":"P Murtra","year":"2000","unstructured":"Murtra P, Sheasby AM, Hunt SP, de Felipe C (2000) Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405:180\u2013183","journal-title":"Nature"},{"key":"1736_CR89","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cne.903470208","volume":"347","author":"Y Nakaya","year":"1994","unstructured":"Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994) Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347:249\u2013274","journal-title":"J Comp Neurol"},{"key":"1736_CR90","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/00001756-199908020-00013","volume":"10","author":"S Nikolaus","year":"1999","unstructured":"Nikolaus S, Huston JP, Hasenohrl RU (1999a) The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection. NeuroReport 10:2293\u20132296","journal-title":"NeuroReport"},{"key":"1736_CR91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(99)00105-3","volume":"370","author":"S Nikolaus","year":"1999","unstructured":"Nikolaus S, Huston JP, Hasenohrl RU (1999b) Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. Eur J Pharmacol 370:93\u201399","journal-title":"Eur J Pharmacol"},{"key":"1736_CR92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)00902-2","volume":"283","author":"S Nikolaus","year":"2000","unstructured":"Nikolaus S, Huston JP, Hasenohrl RU (2000) Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P. Neurosci Lett 283:37\u201340","journal-title":"Neurosci Lett"},{"key":"1736_CR93","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.4049\/jimmunol.150.12.5281","volume":"150","author":"DA Nio","year":"1993","unstructured":"Nio DA, Moylan RN, Roche JK (1993) Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol 150:5281\u20135288","journal-title":"J Immunol"},{"key":"1736_CR94","first-page":"407","volume":"18","author":"B Norman","year":"1998","unstructured":"Norman B (1998) A placebo-controlled, in-clinic study to explore the preliminary safety and efficacy of intravenous L-758,298 (a prodrug of the NK-1 receptor antagonist L-754,030) in the acute treatment of migraine. Cephalalgia 18:407","journal-title":"Cephalalgia"},{"key":"1736_CR95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"TM O\u2019Connor","year":"2004","unstructured":"O\u2019Connor TM, O\u2019Connell J, O\u2019Brien DI, Goode T, Bredin CP, Shanahan F (2004) The role of substance P in inflammatory disease. J Cell Physiol 201:167\u2013180","journal-title":"J Cell Physiol"},{"key":"1736_CR96","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00520-012-1696-0","volume":"21","author":"IN Olver","year":"2013","unstructured":"Olver IN, Grimison P, Chatfield M, Stockler MR, Toner GC, Gebski V, Harrup R, Underhill C, Kichenadasse G, Singhal N, Davis ID, Boland A, McDonald A, Thomson D, Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2013) Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Suport Care Cancer 21:1561\u20131568","journal-title":"Suport Care Cancer"},{"key":"1736_CR97","first-page":"52","volume":"71","author":"DW Pascual","year":"1990","unstructured":"Pascual DW, Bost KL (1990) Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. Immunology 71:52\u201356","journal-title":"Immunology"},{"key":"1736_CR98","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00001756-199506090-00018","volume":"6","author":"HW Pfister","year":"1995","unstructured":"Pfister HW, K\u00fcmpfel T, Koedel U (1995) Involvement of substance P in pial arteriolar vasodilatation during pneumococcal meningitis in the rat. NeuroReport 6:1301\u20131305","journal-title":"NeuroReport"},{"key":"1736_CR99","first-page":"L831","volume":"277","author":"G Piedimonte","year":"1999","unstructured":"Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X (1999) Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 277:L831\u2013L840","journal-title":"Am J Physiol"},{"key":"1736_CR100","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.4049\/jimmunol.176.6.3813","volume":"176","author":"P Puneet","year":"2006","unstructured":"Puneet P, Hegde A, Ng SW, Lau HY, Lu J, Moochhala SM, Bhatia M (2006) Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J Immunol 176:3813\u20133820","journal-title":"J Immunol"},{"key":"1736_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4179(98)90015-4","volume":"32","author":"L Quartara","year":"1998","unstructured":"Quartara L, Maggi CA (1998) The tachykinin NK1 receptor part II: distribution and pathophysiological roles. Neuropeptides 32:1\u201349","journal-title":"Neuropeptides"},{"key":"1736_CR102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/all.12052","volume":"68","author":"R Ramalho","year":"2013","unstructured":"Ramalho R, Almeida J, Beltr\u00e3o M, Pirraco A, Costa R, Sokhatska O, Guard\u00e3o L, Palmares C, Guimar\u00e3es JT, Delgado L, Moreira A, Soares R (2013) Substance P antagonist improves both obesity and asthma in a mouse model. Allergy 68:48\u201354","journal-title":"Allergy"},{"key":"1736_CR103","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0306-4522(90)90007-Q","volume":"36","author":"MS Reid","year":"1990","unstructured":"Reid MS, Herrera-Marschitz M, H\u00f6kfelt T, Ohlin M, Valentino KL, Ungerstedt U (1990a) Effects of intranigral substance P and neurokinin A on striatal dopamine release-I. Interactions with substance P antagonists. Neuroscience 36:643\u2013658","journal-title":"Neuroscience"},{"key":"1736_CR104","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1748-1716.1990.tb09030.x","volume":"140","author":"MS Reid","year":"1990","unstructured":"Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U (1990b) Striatal dopamine and glutamate release: effects of intranigral injections of substance P. Acta Physiol Scand 140:527\u2013537","journal-title":"Acta Physiol Scand"},{"key":"1736_CR105","first-page":"168","volume":"63","author":"R Reinhardt","year":"1998","unstructured":"Reinhardt R (1998) Comparison of neurokinin-1 antagonist, L-745,030, to placebo, acetaminophen and ibuprofen in the dental pain model. Clin Pharmacol Ther 63:168","journal-title":"Clin Pharmacol Ther"},{"key":"1736_CR106","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0028-3908(02)00295-2","volume":"43","author":"TL Ripley","year":"2002","unstructured":"Ripley TL, Gadd CA, De Felipe C, Hunt SP, Stephens DN (2002) Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43:1258\u20131268","journal-title":"Neuropharmacology"},{"key":"1736_CR107","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/01.anes.0000291454.90754.de","volume":"107","author":"HL Rittner","year":"2007","unstructured":"Rittner HL, Lux C, Labuz D, Mousa SA, Ach\u00e4fer M, Stein C, Brack A (2007) Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology 107:1009\u20131017","journal-title":"Anesthesiology"},{"key":"1736_CR108","first-page":"76","volume":"2","author":"P Robinson","year":"2009","unstructured":"Robinson P, Garza A, Moore J, Eckols TK, Parti S, Balaji V, Vallejo J, Tweardy DJ (2009) Substance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med 2:76\u201386","journal-title":"Int J Clin Exp Med"},{"key":"1736_CR109","doi-asserted-by":"crossref","first-page":"e1002489","DOI":"10.1371\/journal.ppat.1002489","volume":"8","author":"P Robinson","year":"2012","unstructured":"Robinson P, Garza A, Weinstock J, Serpa JA, Goodman JC, Eckols KT, Firozgary B, Tweardy DJ (2012) Substance P causes seizures in neurocysticercosis. PLoS Pathog 8:e1002489","journal-title":"PLoS Pathog"},{"key":"1736_CR110","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2174\/092986711797200444","volume":"18","author":"FD Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez FD, Cove\u00f1as R (2011) Targeting opioid and neurokinin-1 receptors to treat alcoholism. Curr Med Chem 18:4321\u20134334","journal-title":"Curr Med Chem"},{"key":"1736_CR111","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0167-5699(90)90070-P","volume":"11","author":"ZF Rosenberg","year":"1990","unstructured":"Rosenberg ZF, Fauci AS (1990) Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 11:176\u2013180","journal-title":"Immunol Today"},{"key":"1736_CR112","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1096\/fasebj.5.10.1676689","volume":"5","author":"ZF Rosenberg","year":"1991","unstructured":"Rosenberg ZF, Fauci AS (1991) Immunopathogenesis of HIV infection. FASEB J 5:2382\u20132390","journal-title":"FASEB J"},{"key":"1736_CR113","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0196-9781(85)90142-1","volume":"6","author":"MR Ruff","year":"1985","unstructured":"Ruff MR, Wahl SM, Pert CB (1985) Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6:107\u2013111","journal-title":"Peptides"},{"key":"1736_CR114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3959(96)03109-0","volume":"67","author":"NM Rupniak","year":"1996","unstructured":"Rupniak NM, Carlson EC, Boyce S, Webb JK, Hill RG (1996) Enantioselective inhibition of the formalin paw late phase by the NK-1 receptor antagonist L-733,060 in gerbils. Pain 67:189\u2013195","journal-title":"Pain"},{"key":"1736_CR115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0028-3908(00)00052-6","volume":"39","author":"NM Rupniak","year":"2000","unstructured":"Rupniak NM, Carlson EC, Harrison T, Oates B, Seward E, Owen S, de Felipe C, Hunt S, Wheeldon A (2000) Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39:1413\u20131421","journal-title":"Neuropharmacology"},{"key":"1736_CR116","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008877-200111000-00011","volume":"12","author":"NM Rupniak","year":"2001","unstructured":"Rupniak NM, Calrson EJ, Webb JK, Harrison T, Porsolt RD, Roux S, de Felipe C, Hunt SP, Oates B, Wheeldon A (2001) Comparison of the phenotype of NK1R-\/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 12:497\u2013508","journal-title":"Behav Pharmacol"},{"key":"1736_CR501","doi-asserted-by":"crossref","unstructured":"Sachais BS, Snider RM, Lowe JA 3rd, Krause JE (1993) Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J Biol Chem 268:2319\u20132323","DOI":"10.1016\/S0021-9258(18)53777-7"},{"key":"1736_CR117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0196-9781(88)90255-0","volume":"9","author":"M Saffroy","year":"1988","unstructured":"Saffroy M, Beaujouan JC, Torrens Y, Besseyre J, Bergstrom L, Glowinski J (1988) Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides 9:227\u2013241","journal-title":"Peptides"},{"key":"1736_CR118","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/annonc\/mds541","volume":"24","author":"H Saito","year":"2013","unstructured":"Saito H, Yoshizawa H, Yoshimori K, Katakami N, Katsumata N, Kawahara M, Eguchi K (2013) Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-bind, placebo-controlled phase 3 trial. Ann Oncol 24:1067\u20131073","journal-title":"Ann Oncol"},{"key":"1736_CR119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00240-7","volume":"84","author":"M Samsam","year":"2000","unstructured":"Samsam M, Cove\u00f1as R, Ahangari R, Yajeya J, Narv\u00e1ez JA, Tramu G (2000) Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion. Pain 84:389\u2013395","journal-title":"Pain"},{"key":"1736_CR120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0891-0618(01)00088-6","volume":"21","author":"M Samsam","year":"2001","unstructured":"Samsam M, Cove\u00f1as R, Csillik B, Ahangari R, Yajeya J, Riquelme R, Narv\u00e1ez JA, Tramu G (2001) Depletion of substance P, neurokinin A and calcitonin gene-related peptide from the contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; A possible neurophysiological and neuroanatomical link to generalized head pain. J Chem Neuroanat 21:161\u2013169","journal-title":"J Chem Neuroanat"},{"key":"1736_CR121","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1470-2045(12)70373-X","volume":"13","author":"D Santini","year":"2012","unstructured":"Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, Frezza AM, Berti P, Tonini G (2012) Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol 13:1020\u20131024","journal-title":"Lancet Oncol"},{"key":"1736_CR122","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neuropharm.2004.02.013","volume":"46","author":"SB Sartori","year":"2004","unstructured":"Sartori SB, Burnet PWJ, Sharp T, Singewald N (2004) Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain. Neuropharmacology 46:1177\u20131183","journal-title":"Neuropharmacology"},{"key":"1736_CR123","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.4049\/jimmunol.158.8.3895","volume":"158","author":"P Schratzberger","year":"1997","unstructured":"Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ (1997) Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 158:3895\u20133901","journal-title":"J Immunol"},{"key":"1736_CR124","first-page":"733","volume":"63","author":"R Scicchinato","year":"1988","unstructured":"Scicchinato R, Biennenstock J, Stanisz AM (1988) In vivo immunomodulation by the neuropeptide substance P. Immunology 63:733\u2013735","journal-title":"Immunology"},{"key":"1736_CR125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(85)90102-8","volume":"846","author":"H Shibata","year":"1985","unstructured":"Shibata H, Mio M, Tasaka K (1985) Analysis of the mechanism of histamine release induced by substance P. Biochem Biophys Acta 846:1\u20137","journal-title":"Biochem Biophys Acta"},{"key":"1736_CR126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(96)00812-8","volume":"739","author":"Y Shirayama","year":"1996","unstructured":"Shirayama Y, Mitsushio H, Takashima M, Ichinawa H, Takahashi K (1996) Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat. Brain Res 739:70\u201378","journal-title":"Brain Res"},{"key":"1736_CR127","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1073\/pnas.97.1.388","volume":"97","author":"D Singh","year":"2000","unstructured":"Singh D, Joshi DD, Hameed M, Qian J, Gasc\u00f3n P, Maloof PB, Mosenthal A, Rameshwar P (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci USA 97:388\u2013393","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0306-4522(86)90081-3","volume":"17","author":"G Sperk","year":"1986","unstructured":"Sperk G, Wieser R, Widmann R, Singer EA (1986) Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience 17:1117\u20131126","journal-title":"Neuroscience"},{"key":"1736_CR129","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(96)91015-6","volume":"347","author":"MB Sporn","year":"1996","unstructured":"Sporn MB (1996) The war on cancer. Lancet 347:1377\u20131381","journal-title":"Lancet"},{"key":"1736_CR130","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","volume":"5","author":"S St\u00e4nder","year":"2010","unstructured":"St\u00e4nder S, Siepmann D, Herrgott I, Sunderk\u00f6tter C, Luger TA (2010) Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 5:e10968","journal-title":"PLoS One"},{"key":"1736_CR131","doi-asserted-by":"crossref","first-page":"e24180","DOI":"10.1371\/journal.pone.0024180","volume":"6","author":"P Tebas","year":"2011","unstructured":"Tebas P, Tuluc F, Barret JS, Wagner W, Kim D, Zhao H, Gonin R, Korelitz J, Douglas SD (2011) A randomized, placebo controlled, double masked phase Ib study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults. PLoS One 6:e24180","journal-title":"PLoS One"},{"key":"1736_CR132","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.npep.2012.10.005","volume":"47","author":"FC Teodoro","year":"2013","unstructured":"Teodoro FC, Tronco J\u00fanior MF, Zampronio AR, Martini AC, Rae GA, Chichorro JG (2013) Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models. Neuropeptides 47:199\u2013206","journal-title":"Neuropeptides"},{"key":"1736_CR133","doi-asserted-by":"crossref","first-page":"e34138","DOI":"10.1371\/journal.pone.0034138","volume":"7","author":"E Thornton","year":"2012","unstructured":"Thornton E, Vink R (2012) Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson\u2019s disease. PLoS One 7:e34138","journal-title":"PLoS One"},{"key":"1736_CR134","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-010-1775-1","volume":"209","author":"A Thorsell","year":"2010","unstructured":"Thorsell A, Schank JR, Singley E, Hunt SP, Heilig M (2010) Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology 209:103\u2013111","journal-title":"Psychopharmacology"},{"key":"1736_CR135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1665-2681(19)31658-8","volume":"9","author":"M Trivedi","year":"2010","unstructured":"Trivedi M, Bergasa NV (2010) Serum concentrations of substance P in cholestasis. Ann Hepatol 9:177\u2013180","journal-title":"Ann Hepatol"},{"key":"1736_CR136","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1167\/iovs.11-8089","volume":"52","author":"BS Twardy","year":"2011","unstructured":"Twardy BS, Channappanavar R, Suvas S (2011) Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions. Invest Ophthalmol Vis Sci 52:8604\u20138613","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1736_CR137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(81)90384-8","volume":"71","author":"T Unger","year":"1981","unstructured":"Unger T, Rascher W, Schuster C, Pavlovitch R, Sch\u00f6mig A, Dietz R, Ganten D (1981) Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur J Pharmacol 71:33\u201342","journal-title":"Eur J Pharmacol"},{"key":"1736_CR138","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1301586","volume":"33","author":"TL Wallace-Boone","year":"2008","unstructured":"Wallace-Boone TL, Newton AE, Wright RN, Lodge NJ, McElroy JF (2008) Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists. Neuropsychopharmacology 33:1919\u20131928","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR139","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(85)90598-0","volume":"332","author":"SS Wolf","year":"1985","unstructured":"Wolf SS, Moody TW, Quirion R, O\u2019Donohue TL (1985) Biochemical characterization and autoradiographic localization of central SP receptor using [125I] physalaemin. Brain Res 332:299\u2013307","journal-title":"Brain Res"},{"key":"1736_CR140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1471-4159.2002.01155.x","volume":"83","author":"J Yu","year":"2002","unstructured":"Yu J, Cadet JL, Angulo JA (2002) Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem 83:613\u2013622","journal-title":"J Neurochem"},{"key":"1736_CR141","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-328X(98)00191-0","volume":"60","author":"O Zachrisson","year":"1998","unstructured":"Zachrisson O, Lindefors N, Bren\u00e9 S (1998) A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Res Mol Brain Res 60:291\u2013295","journal-title":"Brain Res Mol Brain Res"},{"key":"1736_CR142","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0026-2862(90)90024-L","volume":"40","author":"M Ziche","year":"1990","unstructured":"Ziche M, Morbidelli L, Pacini M, Gepetti P, Alessandri G, Maggi CA (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264\u2013278","journal-title":"Microvasc Res"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-014-1736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-014-1736-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-014-1736-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T22:20:01Z","timestamp":1689114001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-014-1736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,6]]},"references-count":144,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s00726-014-1736-9","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,6]]}}}